Compare Danaher Corporation (DHR) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Liberty Global Ltd Class C — how do they compare? Danaher Corporation trades at $219.58 (market cap $152.87B), while Liberty Global Ltd Class C trades at $8.24 (market cap $3.06B). The key difference: Danaher Corporation is far larger — about 50× Liberty Global Ltd Class C's market cap, and Danaher Corporation pays a 0.74% dividend while Liberty Global Ltd Class C pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Liberty Global Ltd Class C for 21 Days on average.
| DHR | LBTYK | |
|---|---|---|
Market Cap | $152.87B | $3.06B |
Volume | 5,228,698 | 2,508,956 |
Sector | Health | Media |
52-Week High | $242.05 | $12.67 |
52-Week Low | $161.91 | $8.75 |
Typical Hold Time | 69 Days | 21 Days |
Enterprise Value | $175.08B | $9.72B |
Dividend Yield | 0.74% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
LBTYK trades at $8.65, down 3.03% today and near 52-week lows. The stock shows bearish technical signals with negative earnings trends, including a Q3 2026 net loss of -$3.0B. However, strong analyst support (69% buy ratings) and a $12.67 price target suggest potential upside. Recent developments include the Ziggo Group spin-off preparation and AI partnership with Sierra.
The outlook remains cautious due to persistent losses and bearish technicals, but strategic moves like Ziggo's 2027 listing and solid cash flow ($602M net in 2026) offer recovery potential. Key risks include execution challenges and competitive pressures, while institutional sentiment provides a floor for valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
